Epidemiology and the "Silent Crisis" of UK Gout
Gout in the UK is increasingly recognized not just as a joint condition, but as a marker of cardiovascular and metabolic health. As of 2026, there are approximately 1.5 million people living with the condition in England alone. The prevalence is significantly higher in men (3–4%) compared to women (1–2%), with risk factors including obesity, high alcohol consumption, and chronic kidney disease (CKD).
A critical issue identified in 2026 is the link between gout and other systemic diseases. Recent Oxford-led studies have confirmed that untreated hyperuricaemia (high uric acid) is a precursor to several major conditions, including hypertension and heart disease. Despite this, only about one-third of UK patients currently receive effective, target-driven treatment, leading to a "silent crisis" of preventable joint damage and hospital admissions.